References
- Nilvebrant L, Glas G, Jőnsson Å, Sparf B. (1994). The in vitro pharmacological profile of tolterodine-new agent for the treatment of urinary urge incontinence. Neurourol Urodyn, 13:433–435.
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al.; Standardisation Sub-committee of the International Continence Society. (2002). The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 21:167–178.
- Nilvebrant L, Hallén B, Larsson G. (1997). Tolterodine–a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data. Life Sci, 60:1129–1136.
- Brynne N, Dalén P, Alván G, Bertilsson L, Gabrielsson J. (1998). Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine. Clin Pharmacol Ther, 63:529–539.
- Postlind H, Danielson A, Lindgren A, Andersson SH. (1998). Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Drug Metab Dispos, 26:289–293.
- Zhao L, Li Y, Fang L, He Z, Liu X, Wang L et al.(2009). Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation. Int J Pharm, 374:73–81.
- Tan HS, Pfister WR. (1999). Pressure-sensitive adhesives for transdermal drug delivery systems. Pharm Sci Technol Today, 2:60–69.
- Fang L, Kobayashi Y, Numajiri S, Kobayashi D, Sugibayashi K, Morimoto Y. (2002). The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol Pharm Bull, 25:1339–1344.
- Qi X, Liu RR, Sun D, Ackermann C, Hou H. (2003). Convolution method to predict drug concentration profiles of 2,3,5,6-tetramethylpyrazine following transdermal application. Int J Pharm, 259:39–45.
- Toddywala RD, Ulman K, Walters P, Chien YW. (1991). Effect of physicochemical properties of adhesive on the release, skin permeation and adhesiveness of adhesive-type transdermal drug delivery systems (a-TDD) containing silicone-based pressure-sensitive adhesives. Int J Pharm, 76:77–89.
- Wokovich AM, Prodduturi S, Doub WH, Hussain AS, Buhse LF. (2006). Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm, 64:1–8.
- Ho KY, Dodou K. (2007). Rheological studies on pressure-sensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance. Int J Pharm, 333:24–33.
- Inoue K, Ogawa K, Okada J, Sugibayashi K. (2005). Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug. J Control Release, 108:306–318.
- Zhao X, Liu JP, Zhang X, Li Y. (2006). Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm, 327:58–64.
- Karande P, Mitragotri S. (2009). Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta, 1788:2362–2373.
- López A, Llinares F, Cortell C, Herráez M. (2000). Comparative enhancer effects of Span20 with Tween20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm, 202:133–140.
- Panchagnula R, Desu H, Jain A, Khandavilli S. (2005). Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: Role of solubility, partitioning and lipid bilayer perturbation. Farmaco, 60:894–899.
- Leichtnam ML, Rolland H, Wüthrich P, Guy RH. (2006). Identification of penetration enhancers for testosterone transdermal delivery from spray formulations. J Control Release, 113:57–62.
- Kokubo T, Sugibayashi K, Morimoto Y. (1991) Diffusion of drug in acrylic-type pressure-sensitive adhesive matrices. Influence of physical property of the matrices on the drug diffusion. J Control Release, 17:69–78.
- Karande P, Jain A, Mitragotri S. (2006). Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. J Control Release, 115:85–93.